On 28 MAY TherapeuticsMD Inc (NYSEMKT: TXMD) announced the availability of the newly reformulated vitaMedMD(R) branded prescription prenatal vitamin, vitaMedMD RediChew(TM) Rx, and the BocaGreenMD(R) generic prescription prenatal vitamin Prena1 Chew. VitaMedMD RediChew Rx and Prena1 Chew are small, vanilla flavored, chewable prenatal vitamin tablets that dissolve quickly and are taken once daily. TherapeuticsMD Inc (NYSEMKT: TXMD) weekly performance is 5.73%. On last trading day company shares ended up $4.06. Analysts mean target price for the company is $10.00. TherapeuticsMD Inc (NYSEMKT: TXMD) distance from 50-day simple moving average (SMA50) is -14.61%.
NewLink Genetics Corp (NASDAQ:NLNK) announced data from a Phase 2 clinical study of its dorgenmeltucel-L HyperAcute® immunotherapy in combination with pegylated interferon-alpha 2b in patients with advanced metastatic, progressive, refractory or recurrent melanoma. The study will be featured in the upcoming edition of The Ochsner Journal, Academic Division of Ochsner Clinic Foundation. The treatment regimen consisted of 12 weekly vaccinations with 150 million cell dosage of dorgenmeltucel-L in combination with short course, pegylated interferon-alpha 2b given during weeks 5 through 12. NewLink Genetics Corp (NASDAQ:NLNK) shares advanced 3.64% in last trading session and ended the day on $20.51. NLNK return on assets is -44.70%. NewLink Genetics Corp (NASDAQ:NLNK) quarterly performance is -53.60%.
On 28 MAY Gogo Inc (NASDAQ:GOGO) has announced its fiscal results for the quarter that ended 31 March 2014. Gogo Inc (NASDAQ:GOGO) reported its record Q1 revenue of $95.7M, an increase of 35% year-over-year. The adjusted EBITDA for the Q1 2014 was $5.3M, an increase of 87% from $2.9M in the Q1 2013. This was driven by the strong performance by the company’s CA-NA & BA segments that were also partially offset by the increased segment-loss in its CA-ROW segment as the company continues to invest in its global expansion. Gogo Inc (NASDAQ:GOGO) shares moved down -3.11% in last trading session and was closed at $18.09, while trading in range of $17.40 – $18.85. Gogo Inc (NASDAQ:GOGO) year to date (YTD) performance is -27.12%.
Marketo Inc (NASDAQ:MKTO) reported ($0.18) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.29) by $0.11. The company had revenue of $32.30 million for the quarter, compared to the consensus estimate of $30.12 million. During the same quarter in the prior year, the company posted ($2.64) earnings per share. The company’s quarterly revenue was up 64.0% on a year-over-year basis. Analysts expect that Marketo will post $-1.02 EPS for the current fiscal year. Marketo Inc (NASDAQ:MKTO) ended the last trading day at $23.18. Company weekly volatility is calculated as 4.40% and price to cash ratio as 7.85. Marketo Inc (NASDAQ:MKTO) showed a negative weekly performance of -5.50%.
On 21 MAY E-House (China) Holdings Limited (ADR) (NYSE:EJ) announced its Q1 FY2014 financial results. For Q1 FY2014, the company reported net income attributable to E-House China Holdings Ltd of $2.90 million, or $0.02 per diluted share. E-House (China) Holdings Limited (ADR) (NYSE:EJ) net profit margin is 7.10% and weekly performance is -4.27%. On last trading day company shares ended up $9.42. Analysts mean target price for the company is $17.78. E-House (China) Holdings Limited (ADR) (NYSE:EJ) distance from 50-day simple moving average (SMA50) is -7.97%.